Emerging role of biosimilars: Focus on trastuzumab and metastatic human epidermal growth factor receptor 2-positive breast cancer Article

cited authors

  • Sarder, Lyudmila U.; Ahmad, Sarfraz

authors

Publication Date

  • December 1, 2023

webpage

published in

category

keywords

  • Biosimilars
  • Breast cancer
  • Cost-effectiveness
  • HER2-positive
  • Trastuzumab
  • Treatment

volume

  • 6